Dexcom (DXCM) Other Operating Expenses (2010 - 2022)

Dexcom (DXCM) has 6 years of Other Operating Expenses data on file, last reported at -$5.7 million in Q4 2022.

• Other Operating Expenses for Q4 2022 came in at -$5.7 million, down 106.72% year-over-year; the trailing twelve-month figure through Sep 2023 was -$5.7 million (down 106.3% YoY), and the FY2021 annual result was $87.1 million, up 3384.0% from the prior year.
• Other Operating Expenses fell to -$5.7 million in Q4 2022 per DXCM's latest filing, from $1.8 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $217.7 million in Q4 2018 and troughed at -$5.7 million in Q4 2022.
• A 4-year average of $34.1 million and a median of $1.9 million in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2021 and 2022: Other Operating Expenses surged 3292.0% in 2021, then tumbled 106.72% in 2022.
• A 4-year view of Other Operating Expenses shows it stood at $217.7 million in 2018, then tumbled by 98.85% to $2.5 million in 2020, then surged by 3292.0% to $84.8 million in 2021, then plunged by 106.72% to -$5.7 million in 2022.
• Business Quant data shows DXCM's Other Operating Expenses at -$5.7 million in Q4 2022, $1.8 million in Q3 2022, and $1.9 million in Q2 2022.